AI Article Synopsis

  • The authors discuss 9 cases of bronchial carcinoma patients who survived for 5 years or more.
  • They highlight key factors affecting survival time, including histology (better outcomes with differentiated epidermoid epithelioma), tumor location (apex or trachea tumors having worse prognoses), and treatment methods (curative high-energy radiotherapy being preferred over chemotherapy).
  • Regular check-ups are emphasized as crucial for monitoring health and enabling the early detection of any cancer recurrence, with 7 patients benefiting from this approach.

Article Abstract

The authors report 9 observations of bronchial carcinoma with a surviving time of 5 years or more. They insist on the various factors on which depends the surviving time: --histology: a differentiated epidermoid epithelioma has better results; --localization of the tumour: cancers of the apex or the trachea have a slow evolution but a very bad prognosis; --therapeutical methods: high energy radiotherapy at curative doses is the best medical treatment of bronchial cancer and chemotherapy is only its complement; --prolonged and regular check ups are a major point in this fighting of cancer. Beyond keeping watch on the general health, it enables early detection and treatment of any evolutive recurrence. Seven of their patients benefited from such repeated treatment.

Download full-text PDF

Source

Publication Analysis

Top Keywords

bronchial cancer
8
surviving time
8
[therapeutic survival
4
survival years
4
years medically
4
medically treated
4
treated primary
4
primary bronchial
4
cancer apropos
4
apropos cases]
4

Similar Publications

Radical lymphadenectomy is the critical component of surgery for esophageal cancer. However, lymphadenectomy significantly contributes to postoperative morbidity, particularly in terms of pulmonary complications following esophagectomy. Function-preserving mediastinal lymphadenectomy seeks to balance the procedure's necessary radicality and optimal functional outcomes.

View Article and Find Full Text PDF

An aberrant right subclavian artery (ARSA) is a rare vascular anomaly accompanied by nonrecurrent inferior laryngeal nerve (NRILN). Here, we described the cervical-first approach in thoracoscopic esophagectomy for an esophageal cancer patient with ARSA using the intraoperative nerve monitoring (IONM) system. First, a left cervical procedure proceeded to expose the left vagus nerve to attach the APS electrode of the IONM system, and the left cervical paraesophageal lymph nodes was dissected separately.

View Article and Find Full Text PDF

Background: Malignant esophageal mediastinal fistula is a severe complication that occurs in both the advanced stages of esophageal cancer and after radiotherapy for esophageal cancer. Esophageal mediastinal fistula is very susceptible to complications such as mediastinitis and mediastinal abscess, resulting in a significantly elevated mortality rate for patients. We reported a rare case of esophageal mediastinal fistula after immunotherapy for non-small cell lung cancer (NSCLC).

View Article and Find Full Text PDF

Non-small cell lung cancer (NSCLC) is commonly treated with tyrosine kinase inhibitors (TKIs). However, adverse events from such treatment can lead to treatment discontinuation and additional medical expenditures. Ambulatory care from oncology pharmacists in patient education and symptom management can benefit patients with NSCLC.

View Article and Find Full Text PDF

This study was aimed to evaluate the cost-effectiveness of pembrolizumab with chemotherapy (pembrolizumab combination therapy) and compare it with standard-of-care platinum-based chemotherapy (chemotherapy alone) as a first-line treatment for metastatic nonsquamous NSCLC from the perspective of Taiwan's third-party-payer public health-care system. We used a partitioned survival model with an estimated time horizon of 10 years. The partitioned survival model uses Kaplan-Meier estimates of progression-free and overall survival from the KEYNOTE-189 clinical trial.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!